Pharvaris studies of rare disease drug put on hold by FDA

[cafead]

via Shares in Pharvaris plunged Monday after the Swiss biotechnology company revealed the Food and Drug Administration has suspended testing of its most advanced drug for the rare disease hereditary angioedema.

article source